May 17, 2021
Pharming Group is a developer and producer of human therapeutic proteins and more medical products in Netherlands. Read more
BioCryst is perceived as one of Pharming's biggest rivals. BioCryst was founded in 1986 in Durham, North Carolina. BioCryst is in the Pharmaceuticals field. BioCryst generates $196M less revenue than Pharming.
KalVista is Pharming's #2 rival. KalVista is a Public company that was founded in 2004 in Cambridge, Massachusetts. KalVista competes in the Biotechnology field. Compared to Pharming, KalVista has 173 fewer employees.
Today 6:17 AM
Korea Biomedical Review
Today 3:24 AM
Pharming's revenue is the ranked 24th among it's top 10 competitors. The top 10 competitors average 14.1B. Over the last three quarters, Pharming's revenue has grown by 205.5%. Specifically, in Q4 2020's revenue was $131.2M; in Q3 2020, it was $54M; in Q2 2020, it was $42.9M.
No recent acquisitions found related to Pharming
Since Pharming was founded in 1988, it has participated in 2 rounds of funding. In total Pharming has raised $117.0M. Pharming's last funding round was on May 2017 for a total of $100.0M